Your browser doesn't support javascript.
loading
Leukotriene signaling via ALOX5 and cysteinyl leukotriene receptor 1 is dispensable for in vitro growth of CD34+CD38- stem and progenitor cells in chronic myeloid leukemia.
Dolinska, Monika; Piccini, Alexandre; Wong, Wan Man; Gelali, Eleni; Johansson, Anne-Sofie; Klang, Johannis; Xiao, Pingnan; Yektaei-Karin, Elham; Strömberg, Ulla Olsson; Mustjoki, Satu; Stenke, Leif; Ekblom, Marja; Qian, Hong.
Afiliação
  • Dolinska M; Center for Hematology and Regenerative Medicine, Department of Medicine, Karolinska Institutet, Karolinska University Hospital, SE-141 86 Stockholm, Sweden.
  • Piccini A; Center for Hematology and Regenerative Medicine, Department of Medicine, Karolinska Institutet, Karolinska University Hospital, SE-141 86 Stockholm, Sweden.
  • Wong WM; Department of Laboratory Medicine, Lund University, Sweden.
  • Gelali E; Center for Hematology and Regenerative Medicine, Department of Medicine, Karolinska Institutet, Karolinska University Hospital, SE-141 86 Stockholm, Sweden.
  • Johansson AS; Center for Hematology and Regenerative Medicine, Department of Medicine, Karolinska Institutet, Karolinska University Hospital, SE-141 86 Stockholm, Sweden.
  • Klang J; Center for Hematology and Regenerative Medicine, Department of Medicine, Karolinska Institutet, Karolinska University Hospital, SE-141 86 Stockholm, Sweden.
  • Xiao P; Center for Hematology and Regenerative Medicine, Department of Medicine, Karolinska Institutet, Karolinska University Hospital, SE-141 86 Stockholm, Sweden.
  • Yektaei-Karin E; Department of Hematology, Karolinska University Hospital and Department of Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Strömberg UO; Department of Medical Science and Division of Hematology, University Hospital, Uppsala, Sweden.
  • Mustjoki S; Hematology Research Unit Helsinki, Department of Clinical Chemistry and Hematology, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.
  • Stenke L; Department of Hematology, Karolinska University Hospital and Department of Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Ekblom M; Department of Laboratory Medicine, Lund University, Sweden.
  • Qian H; Center for Hematology and Regenerative Medicine, Department of Medicine, Karolinska Institutet, Karolinska University Hospital, SE-141 86 Stockholm, Sweden. Electronic address: hong.qian@ki.se.
Biochem Biophys Res Commun ; 490(2): 378-384, 2017 08 19.
Article em En | MEDLINE | ID: mdl-28623130
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Células-Tronco Neoplásicas / Araquidonato 5-Lipoxigenase / Células da Medula Óssea / Leucemia Mielogênica Crônica BCR-ABL Positiva / Receptores de Leucotrienos / Antígenos CD34 / ADP-Ribosil Ciclase 1 Tipo de estudo: Prognostic_studies Limite: Adult / Humans Idioma: En Revista: Biochem Biophys Res Commun Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Suécia
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Células-Tronco Neoplásicas / Araquidonato 5-Lipoxigenase / Células da Medula Óssea / Leucemia Mielogênica Crônica BCR-ABL Positiva / Receptores de Leucotrienos / Antígenos CD34 / ADP-Ribosil Ciclase 1 Tipo de estudo: Prognostic_studies Limite: Adult / Humans Idioma: En Revista: Biochem Biophys Res Commun Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Suécia